Evidence map›Paper›PMID 42780816›Full record

ArticleJournal of medical biochemistry2026

Correlation analysis of PGC-1β, HIF-1α and RETN with the degree of joint destruction in gouty arthritis.

Jian Bian, Jianguo Zhang, Bo Zhang, Hongfei Shi

Abstract read
In one paragraph

Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jian BianDepartment of Orthopedic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing Jiangbei Hospital, China.
Jianguo ZhangDepartment of Orthopedic Surgery, The First Affiliated Hospital of Zhengzhou University. No. 1, China.
Bo ZhangDepartment of Orthopedic Surgery, The First Affiliated Hospital of Zhengzhou University. No. 1, China.
Hongfei ShiDepartment of Orthopedic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing Jiangbei Hospital, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To explore the expression levels of resistin (RETN), hypoxia-inducible factor-la (HIF -l<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span> ), and peroxi-some proliferator-activated receptor g coactivator-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span> (PGCip ) in gouty arthritis (GA) patients and to analyse their cor-relations with the degree of joint destruction. Methods: The GA group consisted of 134 patients with GA who were admitted to the hospital between January 2023 and October 2024, while the control group consisted of 134 healthy patients who underwent physical examination in the hospital over the same time period. Serum PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, and RETN expression levels were compared. The expression levels of PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, HIF-1a and RETN in the serum and synovial fluid of patients with different clinical characteristics in the GA group were compared. The degree of joint destruction was categorised into 78 cases in the severe GA subgroup and 56 cases in the mild GA subgroup based on the VAS score of the chief complaint pain scale. Compared with PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, RETN, and bone destruction factors [<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>-crosslinking degradation products (P-CTX), tartrate-resistant acid phosphatase-5b (TRACP5b), and nuclear factor p receptor activator ligand (RANKL)], and inflammatory factors with different degrees of joint destruction, the expression levels of 1p (IL-1 <span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>) were analysed. The correlations between PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, and RETN in serum and synovial fluid, as well as the degree of joint destruction, bone destruction factors, and inflamma-tory factors, were analysed. Results: The expression level of serum PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span> in the GA group was lower than that in the control group, while the expression levels of serum HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span> and RETN were greater than those in the control group (P&lt; 0.05). The expression levels of PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span> in the serum of GA patients at different clinical stages, affected joints, disease courses and annual attack frequencies. The expression levels of <span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>-CTX and TRACP5b in the serum of GA patients at different clinical stages, affected joints, disease courses and annual attack frequencies, and in the severe GA subgroup were greater than those in the mild GA subgroup (P&lt; 0.05). RANKL expression was lower than in the mild GA subgroup (P&lt; 0.05). The serum and synovial fluid levels of PGC-1 <span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, P-CTX, TRACP5b, TNF-<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, and IL-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span> were negatively cor-related with the degree of joint destruction and positively cor-related with the level of RANKL. HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span> and RETN exhibited a negative correlation with RANKL and a positive correlation with the degree of joint degradation, as well as with <span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>-CTX, TRACP5b, TNF-<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, and IL-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>. Conclusions: PGC-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, HIF-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span> and RETN are abnormally expressed in patients with GA and are closely related to the degree of joint destruction, bone destruction factors and inflammatory factors. They are expected to become reli-able indicators for evaluating the occurrence and progres-sion of GA.

Indexed as

correlation analysisgouty arthritisHIF-1αjoint destructionPGC-1βRETN

Identifiers

PMID42780816
PMCPMC13598758

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.